(Q54272050)

27 May 2018

title

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. (English)

1 reference

27 May 2018

1 reference

1 reference

S Wang

1

1 reference

27 May 2018

Q Li

2

1 reference

27 May 2018

K Wang

3

1 reference

27 May 2018

Y Dai

4

1 reference

27 May 2018

J Yang

5

1 reference

27 May 2018

S Xue

6

1 reference

27 May 2018

F Han

7

1 reference

27 May 2018

Q Zhang

8

1 reference

27 May 2018

J Liu

9

1 reference

27 May 2018

W Wu

10

1 reference

27 May 2018

publication date

14 February 2013

1 reference

27 May 2018

Clinical and Translational Oncology

published in

1 reference

27 May 2018

volume

15

1 reference

27 May 2018

issue

10

1 reference

27 May 2018

page(s)

849-854

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s12094-013-1014-4

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Systemic therapy of advanced urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Natural history of surgically treated bladder carcinoma with extravesical tumor extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Correlation between p53 mutations and HPV in bilharzial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

21 January 2018

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Genetic variants in miRNAs predict bladder cancer risk and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

MicroRNA expression and function in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

miR-31: a crucial overseer of tumor metastasis and other emerging roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

A mammalian microRNA expression atlas based on small RNA library sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1014-4

Differential miRNA expression profiles in bladder urothelial carcinomas

21 January 2018

1 reference

12 December 2020

A MicroRNA expression profile defining the invasive bladder tumor phenotype

1 reference

12 December 2020

The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer

1 reference

12 December 2020

Bladder cancer: state-of-the-art care

1 reference

12 December 2020

Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer

1 reference

12 December 2020

10.1007/S12094-013-1014-4

Identifiers

DOI

1 reference

27 May 2018

release_jj5vnqek6ncp3b5hg5wnjcb3qy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jj5vnqek6ncp3b5hg5wnjcb3qy

24 November 2022

mapped directly with Wikidata item

1 reference

27 May 2018